The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

E-ISSN： 1996-3181|7|6|512-523

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.6, 2008-12, pp. : 512-523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p75NTR as a Therapeutic Target for Neuropsychiatric Diseases

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 70-76

Bentham Science Publishers

Access to resources Recommend Favorite

Calpain as a Potential Therapeutic Target in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 305-312

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Strategy for Parkinson's and Alzheimer's Disease

Current Medicinal Chemistry, Vol. 17, Iss. 25, 2010-09 ,pp. : 2764-2774

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt signalling pathway: a new target for the treatment of osteoporosis

By Rawadi Georges Roman-Roman Sergio

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1063-1077

Informa Healthcare

Access to resources Recommend Favorite

Vasoactive intestinal peptide family as a therapeutic target for Parkinson’s disease

By Gonzalez-Rey Elena Chorny Alejo Fernandez-Martin Amelia Varela Nieves Delgado Mario

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 923-929

Informa Healthcare

Access to resources Recommend Favorite